Connecticut Addiction Medicine, LLC

Connecticut Addiction Medicine, LLC was paid $21.11M by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	95,671	$3.79M
2019	91,421	$3.91M
2020	79,191	$3.94M
2021	74,806	$3.15M
2022	50,049	$2.50M
2023	52,863	$2.39M
2024incomplete	28,917	$1.43M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	42%	120,799	57,166	$8.82M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	23%	111,241	44,755	$4.75M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	19%	126,867	43,190	$4.11M
90853	Group psychotherapy (other than of a multiple-family group)	8.5%	73,903	30,175	$1.79M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	2.8%	17,392	7,307	$582K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	5,900	3,992	$201K
99205	Prolong outpt/office vis	<1%	1,709	1,421	$200K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	4,528	2,760	$163K
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	<1%	1,421	838	$109K
90792	Psychiatric diagnostic evaluation with medical services	<1%	1,125	716	$97K
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	<1%	1,560	946	$83K
90791	Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation	<1%	815	576	$58K

12 more codes

99215	Doctor's office visit, returning patient (complex)	<1%	566	$46K
99354		<1%	665	$34K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	851	$16K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,291	$14K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	307	$10K
98967		<1%	137	$8K
99406		<1%	1,436	$6K
98968		<1%	20	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	52	$1K
90785		<1%	237	$559.39
99407		<1%	58	$556.71
G0436	Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes	0%	38	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialINGOLD, TIFFANY (OFFICE MANAGER)